Member Exclusive

ASM Microbe 2018: Summit Therapeutics unveils second novel target for gonorrhea

At ASM Microbe (7–11 June, 2018), Summit Therapeutics announced the discovery of a second novel drug target to treat gonorrhea infection, highlighting the power of the Discuva platform.

Go to the profile of Jasmine Harris
Jun 11, 2018
0
0

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.